Corticostriatal synaptic function in mouse models of Huntington's disease: early effects of huntingtin repeat length and protein load
- 14 December 2007
- journal article
- Published by Wiley in The Journal of Physiology
- Vol. 585 (3) , 817-831
- https://doi.org/10.1113/jphysiol.2007.142448
Abstract
Huntington's disease (HD) is an autosomal dominant, late onset, neurodegenerative disease characterized by motor deficits and dementia that is caused by expansion of a CAG repeat in the HD gene. Clinical manifestations result from selective neuronal degeneration of predominantly GABAergic striatal medium‐sized spiny neurons (MSNs). A growing number of studies demonstrate that personality, mood and cognitive disturbances are some of the earliest signs of HD and may reflect synaptic dysfunction prior to neuronal loss. Previous studies in striatal MSNs demonstrated early alterations in NMDA‐type glutamate receptor currents in several HD mouse models, as well as evidence for presynaptic dysfunction prior to disease manifestations in the R6/2 HD fragment mouse model. We have compared corticostriatal synaptic function in full‐length, human HD gene‐carrying YAC transgenic mice expressing a non‐pathogenic CAG repeat (YAC18; control) with three increasingly severe variants of pathogenic HD gene‐expressing mice (YAC72 and two different lines of YAC128), at ages that precede any detectable disease phenotype. We report presynaptic dysfunction and a propensity towards synaptic depression in YAC72 and YAC128 compared to YAC18 mice, and, in the most severe model, we also observed altered AMPA receptor function. When normalized to evoked AMPAR currents, postsynaptic NMDAR currents are augmented in all three pathogenic HD YAC variants. These findings demonstrate multiple perturbations to corticostriatal synaptic function in HD mice, furthering our understanding of the early effects of the HD mutation that may contribute to cognitive dysfunction, mood disorders and later development of more serious dysfunction. Furthermore, this study provides a set of neurophysiological sequelae against which to test and compare other mouse models and potential therapies in HD.Keywords
This publication has 103 references indexed in Scilit:
- Verbal episodic memory declines prior to diagnosis in Huntington's diseaseNeuropsychologia, 2007
- The corticostriatal pathway in Huntington's diseaseProgress in Neurobiology, 2006
- Pro-survival signalling from the NMDA receptorBiochemical Society Transactions, 2006
- Levels of mutant huntingtin influence the phenotypic severity of Huntington disease in YAC128 mouse modelsNeurobiology of Disease, 2006
- Transiently higher release probability during critical period at thalamocortical synapses in the mouse barrel cortex: relevance to differential short‐term plasticity of AMPA and NMDA EPSCs and possible involvement of silent synapsesEuropean Journal of Neuroscience, 2004
- NR2B-Containing Receptors Mediate Cross Talk among Hippocampal SynapsesJournal of Neuroscience, 2004
- Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's diseaseMolecular and Cellular Neuroscience, 2004
- Mutant Huntingtin Enhances Excitotoxic Cell DeathMolecular and Cellular Neuroscience, 2001
- Molecular mechanisms associated with long-term consolidation of the NMDA signalsLife Sciences, 2000
- Role of excitotoxicity in human neurological diseaseCurrent Opinion in Neurobiology, 1992